Cengiz Korkmaz profile image
Cengiz Korkmaz
Publication 10 Review 0 CrossRef Cited 1
10 Publication
0 Review
1 CrossRef Cited

Institution

Popular Publications

COVID-19 Vaccines Can Initiate or Exacerbate A Rheumatic Disease; A Report of 4 Cases
Authors: Reşit Yıldırım , Döndü Üsküdar Cansu , Mustafa Dinler , Cengiz Korkmaz
Published: 2022 , Osmangazi Tıp Dergisi
DOI: 10.20515/otd.1035188
CITED 0 FAVORITE 1 TOTAL DOWNLOAD COUNT 452

0

1

452

Publications

Evaluation of Causes of Hyperkalemia in Systemic Lupus Erythematosus Patients: Retrospective Single-Center Experience
Authors: Afida Mammadova , Döndü Üsküdar Cansu , Cengiz Korkmaz
Published: 2023 , Osmangazi Tıp Dergisi
DOI: 10.20515/otd.1162497
FAVORITE 0 TOTAL DOWNLOAD COUNT 581

0

581

COVID-19 Vaccines Can Initiate or Exacerbate A Rheumatic Disease; A Report of 4 Cases
Authors: Reşit Yıldırım , Döndü Üsküdar Cansu , Mustafa Dinler , Cengiz Korkmaz
Published: 2022 , Osmangazi Tıp Dergisi
DOI: 10.20515/otd.1035188
FAVORITE 1 TOTAL DOWNLOAD COUNT 452

1

452

Are Regulatory T Cell Levels Different in Active and Inactive Systemic Lupus Erythematosus Patients?
Authors: Hava Üsküdar Teke , Döndü Üsküdar Cansu , Cengiz Bal , Cengiz Korkmaz
Published: 2020 , Osmangazi Tıp Dergisi
DOI: 10.20515/otd.463208
FAVORITE 0 TOTAL DOWNLOAD COUNT 2112

0

2112

Bir Üniversite Hastanesinde Romatoid Artrit Tanılı Hastaların Umutsuzluk Düzeylerinin Ve Yaşam Kalitelerinin Belirlenmesi
Authors: Gülsüm Öztürk Emiral , Egemen Ünal , Burcu Isıktekin Atalay , Didem Arslantaş , Alaettin Ünsal , Cengiz Korkmaz
Published: 2019 , Medical Research Reports
DOI: -
FAVORITE 0 TOTAL DOWNLOAD COUNT 862

0

862

Tubulointerstitial Nephritis and Uveitis (TINU) Syndrome: A Case Report and Review of Literatüre
Authors: Erdal Bodakçi , Döndü Üsküdar Cansu , Cengiz Korkmaz
Published: 2019 , Osmangazi Tıp Dergisi
DOI: 10.20515/otd.515086
FAVORITE 0 TOTAL DOWNLOAD COUNT 1021

0

1021

Clinical and Laboratory Results and Prognosis Patients with Scleroderma: A Single Center Experience
Authors: Ebru Özden Yılmaz, Döndü Üsküdar Cansu , Cengiz Korkmaz
Published: 2018 , Osmangazi Tıp Dergisi
DOI: 10.20515/otd.415387
FAVORITE 0 TOTAL DOWNLOAD COUNT 983

0

983

Assessment of Peripheral Blood Regulatory T Cells And T Helper 17 Cells in Patients with Systemic Scleroderma
Authors: Döndü Üsküdar Cansu , Hava Üsküdar Teke , Cengiz Korkmaz
Published: 2018 , Osmangazi Tıp Dergisi
DOI: 10.20515/otd.395894
FAVORITE 0 TOTAL DOWNLOAD COUNT 2162

0

2162

Certolizumab Pegol Experience in the Treatment of Ulcerative Colitis Resistant Pyoderma Gangrenosum
Authors: Döndü Üsküdar Cansu , Tuncer Temel , Cengiz Korkmaz
Published: 2018 , Osmangazi Tıp Dergisi
DOI: 10.20515/otd.291211
FAVORITE 0 TOTAL DOWNLOAD COUNT 5427

0

5427

PSÖRİATİK ARTRİT TEDAVİSİ: 2015 GÜNCELLEME / PSORIATIC ARTHRITIS TREATMENT: 2015 UPDATE
Authors: Döndü Cansu , Cengiz Korkmaz
Published: 2016 , Osmangazi Tıp Dergisi
DOI: -
FAVORITE 0 TOTAL DOWNLOAD COUNT 16304

0

16304

LYMPHOMA ASSOCIATED CRYOGLOBULINEMIC VASCULITIS: IS IT THE REASON OR THE RESULT?
Authors: Döndü Cansu, Hava Teke , Cengiz Korkmaz
Published: 2016 , Osmangazi Tıp Dergisi
DOI: -
FAVORITE 0 TOTAL DOWNLOAD COUNT 5834

0

5834

Articles published in
Medical Research Reports
Medical Research Reports
Osmangazi Tıp Dergisi
Osmangazi Tıp Dergisi
User doesn't have any peer review duties on DergiPark.

Publications

Clinical and Laboratory Results and Prognosis Patients with Scleroderma: A Single Center Experience
Authors: Ebru Özden Yılmaz, Döndü Üsküdar Cansu , Cengiz Korkmaz
Published: 2018 , Osmangazi Tıp Dergisi
DOI: 10.20515/otd.415387
CITED 1 FAVORITE 0 TOTAL DOWNLOAD COUNT 983

1

0

983

Popular Publications: It is determined automatically by the researchers doing research in DergiPark according to the statistics of being added to the favorites. CrossRef Cited: The citations shown in DergiPark are drawn from CrossRef. For this, the cited and cited articles must be registered in CrossRef (DOI number). ^: Citation numbers are reflected in the system by DergiPark at certain periods.
Interactive Guide Tool
If you want to see the panel introduction, you can click Start Tour.